[go: up one dir, main page]

CN1433818A - Polyhydroxyalkanoates (PHA) blood vessel support and making method thereof - Google Patents

Polyhydroxyalkanoates (PHA) blood vessel support and making method thereof Download PDF

Info

Publication number
CN1433818A
CN1433818A CN03119277A CN03119277A CN1433818A CN 1433818 A CN1433818 A CN 1433818A CN 03119277 A CN03119277 A CN 03119277A CN 03119277 A CN03119277 A CN 03119277A CN 1433818 A CN1433818 A CN 1433818A
Authority
CN
China
Prior art keywords
pbt
phb
peg
solid
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN03119277A
Other languages
Chinese (zh)
Other versions
CN1258382C (en
Inventor
胡平
戈钧
童晓岚
郇春艳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tsinghua University
Original Assignee
Tsinghua University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsinghua University filed Critical Tsinghua University
Priority to CNB031192777A priority Critical patent/CN1258382C/en
Publication of CN1433818A publication Critical patent/CN1433818A/en
Application granted granted Critical
Publication of CN1258382C publication Critical patent/CN1258382C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

一种聚羟基脂肪酸酯血管支架及制备方法,属于生物医学工程领域。本发明提供的血管支架由多孔内膜、实心外膜及加强筋构成,加强筋以带状缠绕在实心外膜表层;所述的多孔内膜、实心外膜及加强筋是由聚羟基丁酸酯、聚羟基丁酸-戊酸酯或聚羟基丁酸-己酸酯中的一种或它们的的共混物与聚乙二醇/聚对苯二甲酸丁二醇酯共聚物共混物制备而成。该血管支架除具有良好的生物相容性、抗凝血性、细胞粘附性和适当的降解速度外,更主要的是使血管支架的机械强度和缝合强度有了大幅度提高。

Figure 03119277

A polyhydroxyalkanoate vascular stent and a preparation method thereof belong to the field of biomedical engineering. The vascular stent provided by the present invention is composed of a porous inner membrane, a solid adventitia and a reinforcing rib, and the reinforcing rib is wound on the surface of the solid adventitia in a band shape; the porous inner membrane, the solid adventitia and the reinforcing rib are made of polyhydroxybutyric acid One of esters, polyhydroxybutyrate-valerate or polyhydroxybutyrate-caproate or their blends and polyethylene glycol/polybutylene terephthalate copolymer blends Prepared. In addition to good biocompatibility, anticoagulant property, cell adhesion and proper degradation speed, the vascular stent greatly improves the mechanical strength and suturing strength of the vascular stent.

Figure 03119277

Description

一种聚羟基脂肪酸酯血管支架及制备方法A kind of polyhydroxyalkanoate vascular stent and preparation method thereof

技术领域technical field

本发明涉及一种由聚羟基脂肪酸酯与聚乙二醇/聚对苯二甲酸丁二醇酯共聚物共混制成的血管支架及其制备方法,属于生物医学工程技术领域。The invention relates to a blood vessel stent made by blending polyhydroxyalkanoate and polyethylene glycol/polybutylene terephthalate copolymer and a preparation method thereof, belonging to the technical field of biomedical engineering.

背景技术:Background technique:

目前对直径不超过6mm患病血管的主要医疗方法是用自体血管作迂回旁路代替病变血管,但基于许多病人体内没有适当的和足够的血管用作迂回旁路,产生了用合成材料制备血管支架的想法。合成材料制备的血管用作迂回旁路的基本想法是将组织细胞吸附在生物相容性良好、可在人体内逐步被降解吸收的支架材料上,并给细胞提供营养使之扩增。在支架材料逐步被人体降解吸收的同时,细胞不断增殖并分泌基质,最终形成新的、具有与原来功能和形态相应的血管,达到修复和重建功能的目的。目前,使用的血管支架材料主要是高分子聚合物材料,分为生物非降解聚合材料和生物降解聚合材料。早期制作血管的材料通常采用非降解性聚合材料,如聚四氟乙烯(polytetrafluoroethylene,PTFE),聚氯乙烯(polyvinylchliride,PVC),聚乙烯(polyethylene,PE),聚酯纤维(Dacron)等,这些材料制成的人造血管直接植入体内后,会产生一系列不良反应,形成血栓,堵塞血管。生物降解聚合材料是随着组织工程这一新领域的发展而逐渐发展起来的。生物降解聚合材料通常有聚乙醇酸(polyglycolic acid,PGA),聚羟基辛酯(po1yhydroxyoctanoate,PHO),聚乳酸(polylactic acid,PLA),或PLA与PGA的共聚物(polylactic-glycolic acid,PLGA)。该类材料构建的血管与细胞的亲合性欠佳,再者就是降解速度不能和组织的再生速度相匹配。新型的生物降解材料聚羟基脂肪酸酯(PHA)制备的血管虽然其生物相容性、细胞粘附性以及降解速度等方面相对于传统材料都有了明显的改善,但在机械性能方面及缝合性能还有待于提高。At present, the main medical method for diseased blood vessels with a diameter of no more than 6mm is to use autologous blood vessels as a detour bypass to replace diseased blood vessels, but because many patients do not have appropriate and sufficient blood vessels for detour bypasses, synthetic materials are used to prepare blood vessels. Bracket ideas. The basic idea of using a blood vessel made of synthetic material as a detour is to adsorb tissue cells on a scaffold material with good biocompatibility that can be gradually degraded and absorbed in the human body, and provide nutrients to the cells to expand them. While the scaffold material is gradually degraded and absorbed by the human body, the cells continue to proliferate and secrete the matrix, and finally form new blood vessels with corresponding original functions and shapes to achieve the purpose of repairing and reconstructing functions. At present, the vascular stent materials used are mainly polymer materials, which are divided into bionon-degradable polymer materials and biodegradable polymer materials. The materials used to make blood vessels in the early days usually use non-degradable polymer materials, such as polytetrafluoroethylene (PTFE), polyvinylchliride (PVC), polyethylene (polyethylene, PE), polyester fiber (Dacron), etc. After the artificial blood vessels made of materials are directly implanted in the body, a series of adverse reactions will occur, such as the formation of thrombus and blockage of blood vessels. Biodegradable polymeric materials are gradually developed with the development of the new field of tissue engineering. Biodegradable polymer materials usually include polyglycolic acid (polyglycolic acid, PGA), polyhydroxyoctanoate (polyhydroxyoctanoate, PHO), polylactic acid (polylactic acid, PLA), or a copolymer of PLA and PGA (polylactic-glycolic acid, PLGA) . The blood vessels constructed by such materials have poor affinity with cells, and the degradation rate cannot match the tissue regeneration rate. Although the biocompatibility, cell adhesion and degradation speed of blood vessels prepared by the new biodegradable material polyhydroxyalkanoate (PHA) have been significantly improved compared with traditional materials, the mechanical properties and suture Performance still needs to be improved.

上面提到的非降解聚合材料,传统的方法是将材料先纺织成片状,然后按照需要裁剪成合适的尺寸,用缝合线将片状材料缝合成管状。如何将降解性聚合材料制备成具有良好的机械性能及缝合性能的血管支架,有待于进一步的研究。For the non-degradable polymeric materials mentioned above, the traditional method is to weave the material into a sheet, then cut it into a suitable size as needed, and sew the sheet into a tube with sutures. How to prepare degradable polymer materials into vascular stents with good mechanical properties and suturing properties remains to be further studied.

发明内容Contents of the invention

本发明的目的是提供一种由聚羟基脂肪酸酯与聚乙二醇/聚对苯二甲酸丁二醇酯共聚物的共混物制备的血管支架及其制备方法,以进一步提高聚羟基脂肪酸酯制备的血管支架的机械强度及缝合性能。The object of the present invention is to provide a kind of vascular stent prepared by the blend of polyhydroxyalkanoate and polyethylene glycol/polybutylene terephthalate copolymer and preparation method thereof, to further improve polyhydroxyalkanoate Mechanical strength and suturing performance of vascular stents prepared from acid esters.

本发明的目的是通过如下技术方案实现的:The purpose of the present invention is achieved through the following technical solutions:

一种聚羟基脂肪酸酯血管支架,其特征在于:该血管支架由多孔内膜、实心外膜及加强筋构成,加强筋以带状缠绕在实心外膜表层;所述的多孔内膜、实心外膜及加强筋是由聚羟基脂肪酸酯与聚乙二醇/聚对苯二甲酸丁二醇酯共聚物的共混物制备而成。A polyhydroxyalkanoate vascular stent is characterized in that: the vascular stent is composed of a porous intima, a solid adventitia and a reinforcing rib, and the reinforcing rib is wound on the surface of the solid adventitia in a band shape; the porous intima, solid The outer membrane and reinforcing ribs are prepared from a blend of polyhydroxyalkanoate and polyethylene glycol/polybutylene terephthalate copolymer.

所述的聚羟基脂肪酸酯为聚羟基丁酸酯(PHB)、聚羟基丁酸-戊酸酯(PHB-HV)、聚羟基丁酸-己酸酯(PHB-HH)中的一种或它们的共混物。The polyhydroxyalkanoate is one of polyhydroxybutyrate (PHB), polyhydroxybutyrate-valerate (PHB-HV), polyhydroxybutyrate-hexanoate (PHB-HH) or their blends.

一种制备聚羟基脂肪酸酯血管支架的方法,其特征在于该方法包括如下步骤:A method for preparing a polyhydroxyalkanoate stent, characterized in that the method comprises the steps:

(1)共混物实心膜的制备:(1) Preparation of blend solid film:

    ①将30~80%的聚羟基脂肪酸酯与20~70%的聚乙二醇/聚对苯二甲酸丁二醇酯共聚物混合,以氯仿为溶剂,水浴加热,配制成浓度为0.03g/ml~0.1g/ml的均一溶液;①Mix 30-80% of polyhydroxyalkanoate and 20-70% of polyethylene glycol/polybutylene terephthalate copolymer, use chloroform as solvent, heat in water bath, and prepare a concentration of 0.03g /ml~0.1g/ml homogeneous solution;

    ②采用流延成膜的方法,将步骤①中的溶液冷却后倒入一副培养皿中,把上下培养皿扣合,使氯仿自然挥发,真空干燥,制得实心膜;②Adopt the method of cast film formation, cool the solution in step ① and pour it into a pair of petri dishes, fasten the upper and lower petri dishes, let the chloroform volatilize naturally, dry in vacuum, and make a solid film;

(2)共混物多孔膜的制备(2) Preparation of blend porous membrane

    ①将食盐过标准筛,精选出直径在50-300μm范围内的NaCl粒子;① Pass the salt through a standard sieve to select NaCl particles with a diameter within the range of 50-300 μm;

    ②将30~80%的聚羟基脂肪酸酯与20~70%的聚乙二醇/聚对苯二甲酸丁二醇酯共聚物混合,以氯仿为溶剂,水浴加热,配制成浓度为0.03g/ml~0.1g/ml的均一溶液;②Mix 30-80% of polyhydroxyalkanoate and 20-70% of polyethylene glycol/polybutylene terephthalate copolymer, use chloroform as solvent, heat in water bath, and prepare a concentration of 0.03g /ml~0.1g/ml homogeneous solution;

    ③在②溶液中加入NaCl粒子,其中NaCl为聚羟基脂肪酸酯和聚乙二醇/聚对苯二甲酸丁二醇酯共聚物总质量的10~20倍,然后加热、搅拌,制成悬浮液;③ Add NaCl particles to the solution in ②, where NaCl is 10 to 20 times the total mass of polyhydroxyalkanoate and polyethylene glycol/polybutylene terephthalate copolymer, then heat and stir to make a suspension liquid;

    ④采用流延成膜的方法,将③中制备好的悬浮液冷却后倒入一副培养皿中,把上下培养皿扣合,使氯仿自然挥发;④Using the method of tape casting to form a film, cool the suspension prepared in ③ and pour it into a pair of petri dishes, and fasten the upper and lower petri dishes to make the chloroform volatilize naturally;

    ⑤取出④中样品,将其浸入去离子水中,定时换水,一段时间后取出多孔膜,先在室内干燥,然后真空干燥,待用;⑤ Take out the sample in ④, immerse it in deionized water, change the water regularly, take out the porous membrane after a period of time, first dry it in the room, then vacuum dry it, and set it aside;

(3)共混物加强筋的制备(3) Preparation of blend reinforcement

    ①将(1)中制得的实心膜剪成宽度范围为1~3mm长条状;① Cut the solid film prepared in (1) into strips with a width ranging from 1 to 3 mm;

    ②将长条状实心膜在低于熔点的温度下均匀加热,将2~3层叠放并用三氯甲烷粘合在一起,制得加强筋;②Heat the strip-shaped solid film evenly at a temperature lower than the melting point, stack 2 to 3 layers and glue them together with chloroform to make a reinforcing rib;

(4)血管支架的制备(4) Preparation of stent

    ①按照实际需要将(1)、(2)、(3)中制得的实心膜、多孔膜以及加强筋剪裁成为合适的尺寸;然后将实心膜和多孔膜平放,均匀加热后,轻压粘接制成双层复合膜;① Cut the solid film, porous film and reinforcing ribs prepared in (1), (2) and (3) into appropriate sizes according to actual needs; then lay the solid film and porous film flat, heat evenly, and press lightly Bonding to make a double-layer composite film;

    ②将得到的复合膜卷起,接缝处用三氯甲烷做粘合剂热粘合,得到内外膜复合的管状物;再将加强筋缠绕在管状物上,即可得到完整的血管支架。② Roll up the obtained composite membrane, and use chloroform as an adhesive to thermally bond the seams to obtain a tubular object with a composite inner and outer membrane; then wind the reinforcing ribs on the tubular object to obtain a complete vascular stent.

本发明所提供的血管支架具有以下优点:本发明采用聚羟基脂肪酸酯与具有良好的生物相容性、良好的生物降解性和很好的力学性能的聚乙二醇/对苯二甲酸丁二醇酯共聚物共混,所构建的血管不仅在其生物相容性、细胞粘附性以及降解速度等方面相对于传统材料都有了明显的改善,而且解决了同类材料在力学性能方面的不足,其断裂伸长率和拉伸强度都有较大的提高。The vascular stent provided by the present invention has the following advantages: the present invention adopts polyhydroxyalkanoate and polyethylene glycol/butylene terephthalate with good biocompatibility, good biodegradability and good mechanical properties The blood vessels constructed by blending glycol ester copolymers not only have obvious improvements in biocompatibility, cell adhesion and degradation speed compared with traditional materials, but also solve the problems of similar materials in terms of mechanical properties. Insufficient, its elongation at break and tensile strength have been greatly improved.

附图说明Description of drawings

图1为本发明提供的血管支架的结构示意图。Fig. 1 is a schematic structural diagram of a vascular stent provided by the present invention.

图中:外层灰色为外层实心膜1;内层黑色为内层多孔膜2;深灰色为加强筋3。In the figure: the outer gray is the outer solid membrane 1; the inner black is the inner porous membrane 2; the dark gray is the rib 3.

具体实施方式Detailed ways

图1为本发明提供的血管支架的结构示意图。该血管支架由实心外膜1、多孔内膜2和加强筋3构成,加强筋3以带状缠绕在实心外膜1的表层;所述的多孔内膜2、实心外膜1及加强筋3是由聚羟基脂肪酸酯与聚乙二醇/聚对苯二甲酸丁二醇酯共聚物的共混物制备而成。Fig. 1 is a schematic structural diagram of a vascular stent provided by the present invention. The vascular stent is composed of a solid adventitia 1, a porous inner membrane 2 and a reinforcing rib 3, and the reinforcing rib 3 is wound on the surface of the solid adventitia 1 in a band shape; the porous inner membrane 2, the solid adventitia 1 and the reinforcing rib 3 It is prepared from a blend of polyhydroxyalkanoate and polyethylene glycol/polybutylene terephthalate copolymer.

本发明中所述的聚羟基脂肪酸酯包括聚羟基丁酸酯(PHB)、聚羟基丁酸-戊酸酯(PHB-HV)、聚羟基丁酸-己酸酯(PHB-HH)及其共混物。The polyhydroxyalkanoate described in the present invention comprises polyhydroxybutyrate (PHB), polyhydroxybutyrate-valerate (PHB-HV), polyhydroxybutyrate-hexanoate (PHB-HH) and its blends.

聚乙二醇/聚对苯二甲酸丁二醇酯共聚物(PEG-CO-PBT)中PEG与PBT质量比为7∶3。The mass ratio of PEG to PBT in polyethylene glycol/polybutylene terephthalate copolymer (PEG-CO-PBT) is 7:3.

聚羟基脂肪酸酯的分子量在30~80万。The molecular weight of polyhydroxyalkanoate is between 300,000 and 800,000.

下面实施例进一步说明本发明的制备方法。The following examples further illustrate the preparation method of the present invention.

实施例1:Example 1:

采用80%聚羟基丁酸-戊酸酯(PHB-HV)与20%聚乙二醇/聚对本二甲酸丁二醇酯(PEG-CO-PBT)共聚物共混制备直径为8mm、长度为50mm的血管支架。80% polyhydroxybutyrate-valerate (PHB-HV) and 20% polyethylene glycol/polybutylene terephthalate (PEG-CO-PBT) copolymer blended to prepare a diameter of 8mm, a length of 50mm vascular stent.

(1)共混物实心膜的制备(1) Preparation of blend solid film

    ①将80%聚羟基丁酸-戊酸酯(PHB-HV)和20%的聚乙二醇/聚对本二甲酸丁二醇按酯(PEG-CO-PBT)及氯仿混和,水浴加热并充分搅拌,配制成浓度0.05g/ml均一的溶液;① Mix 80% polyhydroxybutyrate-valerate (PHB-HV) with 20% polyethylene glycol/polybutylene terephthalate (PEG-CO-PBT) and chloroform, heat in a water bath and fully Stir to prepare a solution with a uniform concentration of 0.05g/ml;

    ②采用流延成膜的方法,将①中制备好的溶液冷却后倒入一副直径为10cm培养皿(此直径可调,下同)中,把上下蒸发皿扣合,让氯仿自然挥发,制得实心膜,控制原料量使膜厚为1~2毫米;②Using the method of cast film formation, cool the solution prepared in ① and pour it into a pair of petri dishes with a diameter of 10cm (the diameter is adjustable, the same below), and fasten the upper and lower evaporating dishes to let the chloroform volatilize naturally. Prepare a solid film, and control the amount of raw materials so that the film thickness is 1 to 2 mm;

(2)共混物多孔膜的制备(2) Preparation of blend porous membrane

    ①将食盐过标准筛,精选出直径在50~300μm的NaCl粒子,① Pass the salt through a standard sieve, select NaCl particles with a diameter of 50-300 μm,

    ②将80%聚羟基丁酸-戊酸酯(PHB-HV)和20%的聚乙二醇/聚对本二甲酸丁二醇按酯(PEG-CO-PBT)及氯仿混和,水浴加热并充分搅拌,配制成浓度0.05g/ml均一的溶液;② Mix 80% polyhydroxybutyrate-valerate (PHB-HV) with 20% polyethylene glycol/polybutylene terephthalate (PEG-CO-PBT) and chloroform, heat in a water bath and fully Stir to prepare a solution with a uniform concentration of 0.05g/ml;

    ③向上述溶液中加入为共混物总质量10倍的NaCl粒子,然后加热、搅拌,制成悬浮液;③ Add NaCl particles 10 times the total mass of the blend to the above solution, then heat and stir to make a suspension;

    ④采用流延成膜的方法,将③中制备好的溶液冷却后倒入一副培养皿(直径为10cm)中,把上下培养皿扣合,使氯仿自然挥发,控制原料量使膜厚为1~2毫米;④Using the method of cast film formation, cool the solution prepared in ③ and pour it into a pair of petri dishes (10cm in diameter), fasten the upper and lower petri dishes together, let the chloroform volatilize naturally, control the amount of raw materials so that the film thickness is 1 to 2 mm;

    ⑤取出④中样品,将其浸入去离子水,每8小时换一次水,浸泡3天之后取出多孔片,先在室内干燥,制得多孔膜;⑤ Take out the sample in ④, immerse it in deionized water, change the water every 8 hours, take out the porous sheet after soaking for 3 days, and dry it indoors first to make a porous membrane;

(3)共混物加强筋的制备(3) Preparation of blend reinforcement

    ①将(1)中制得的实心膜剪成宽度范围为3~5mm长条状;① Cut the solid film prepared in (1) into strips with a width ranging from 3 to 5 mm;

    ②将长条状实心膜在低于熔点的温度下均匀加热,将2~3层叠放并用三氯甲烷粘合在一起,制得加强筋;②Heat the strip-shaped solid film evenly at a temperature lower than the melting point, stack 2 to 3 layers and glue them together with chloroform to make a reinforcing rib;

(4)血管支架的制备(4) Preparation of stent

    ①将(1)、(2)中备用的实心膜和多孔膜裁剪成宽为25mm、长为50mm的尺寸;① Cut the spare solid membrane and porous membrane in (1) and (2) into a size with a width of 25mm and a length of 50mm;

    ②将①中得到的实心膜平放,均匀加热,将多孔膜平铺其上,用少量氯仿做黏合剂,压制成复合膜;② Lay the solid membrane obtained in ① flat, heat it evenly, spread the porous membrane on it, use a small amount of chloroform as an adhesive, and press it into a composite membrane;

    ③用直径8mm的圆纸筒将复合膜卷起,将接缝处用三氯甲烷做粘合剂热粘合,得管状材料;③Roll up the composite film with a circular paper tube with a diameter of 8mm, and thermally bond the joints with chloroform as an adhesive to obtain a tubular material;

    ④将(3)中的加强筋缠绕在③中得到的管状材料上,于是得到完整的血管支架。④Wrap the reinforcing rib in (3) on the tubular material obtained in ③, thus obtaining a complete vascular stent.

实施例2:Example 2:

采用70%聚羟基丁酸酯(PHB)与30%聚乙二醇/聚对本二甲酸丁二醇酯(PEG-CO-PBT)制备直径为3mm、长度为10mm的血管支架。A vascular stent with a diameter of 3 mm and a length of 10 mm was prepared using 70% polyhydroxybutyrate (PHB) and 30% polyethylene glycol/polybutylene terephthalate (PEG-CO-PBT).

(1)共混物实心膜的制备(1) Preparation of blend solid film

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT实心膜的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB/PEG-CO-PBT,其中PHB占70%,PEG-CO-PBT占30%,溶液浓度0.03g/ml,将培养皿的直径调整为6cm;The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT solid film in Example 1, except that PHB-HV/PEG-CO-PBT is replaced by PHB/PEG-CO-PBT, wherein PHB accounts for 70%, PEG-CO-PBT accounts for 30%, the solution concentration is 0.03g/ml, and the diameter of the petri dish is adjusted to 6cm;

(2)共混物多孔膜的制备(2) Preparation of blend porous membrane

制备方法和实施例1中制备PHB-HV/PE-CO-PBT多孔膜的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB/PEG-CO-PBT,其中PHB占70%,PEG-CO-PBT占30%,加入的NaCl为共混物总质量的15倍,NaCl的粒径调整到200~300μm;将培养皿的直径调整为6cm,The preparation method is the same as the method for preparing the PHB-HV/PE-CO-PBT porous membrane in Example 1, except that PHB-HV/PEG-CO-PBT is replaced by PHB/PEG-CO-PBT, wherein PHB accounts for 70%, PEG-CO-PBT accounted for 30%, the added NaCl was 15 times the total mass of the blend, and the particle size of NaCl was adjusted to 200-300 μm; the diameter of the petri dish was adjusted to 6cm,

(3)加强筋的制备(3) Preparation of ribs

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT加强筋的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB/PEG-CO-PBT;The preparation method is the same as the method for preparing PHB-HV/PEG-CO-PBT reinforcing ribs in Example 1, except that PHB-HV/PEG-CO-PBT is replaced by PHB/PEG-CO-PBT;

(4)血管支架(4) Vascular stent

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT血管支架的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB/PEG-CO-PBT,将膜裁剪成宽10mm、长10mm的尺寸,用直径为3mm的圆纸筒将双层膜卷起。The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT vascular stent in Example 1, except that the PHB-HV/PEG-CO-PBT is replaced by PHB/PEG-CO-PBT, and the film is cut to a width of 10mm , 10mm in length, roll up the double-layer film with a round paper tube with a diameter of 3mm.

实施例3:Example 3:

采用60%聚羟基丁酸-己酸酯(PHB-HH)与40%的聚乙二醇/聚对本二甲酸丁二醇酯(PEG-CO-PBT)共混物制备直径为12mm、长度为100mm血管支架。Using 60% polyhydroxybutyrate-hexanoate (PHB-HH) and 40% polyethylene glycol/polybutylene terephthalate (PEG-CO-PBT) blend to prepare 100mm vascular stent.

(1)共混物实心膜制备(1) Blend solid film preparation

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT实心膜的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB-HH/PEG-CO-PBT,其中PEG-CO-PBT占总质量40%,溶液浓度为0.06g/ml,将培养皿的直径换成19cm;The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT solid film in Example 1, except that PHB-HV/PEG-CO-PBT is replaced by PHB-HH/PEG-CO-PBT, wherein PEG-CO -PBT accounts for 40% of the total mass, the solution concentration is 0.06g/ml, and the diameter of the petri dish is changed to 19cm;

(2)共混物多孔膜制备(2) Preparation of blend porous membrane

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT多孔膜的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB-HH/PEG-CO-PBT,其中PEG-CO-PBT占总质量40%,加入的NaCl为共混物总质量的20倍,将NaCl的粒径换为200~300μm;The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT porous membrane in Example 1, except that PHB-HV/PEG-CO-PBT is replaced by PHB-HH/PEG-CO-PBT, wherein PEG-CO - PBT accounts for 40% of the total mass, the added NaCl is 20 times the total mass of the blend, and the particle size of NaCl is changed to 200-300 μm;

(3)共混物加强筋的制备(3) Preparation of blend reinforcement

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT加强筋的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB-HH/PEG-CO-PBT;The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT reinforcing rib in Example 1, except that PHB-HV/PEG-CO-PBT is replaced by PHB-HH/PEG-CO-PBT;

(4)共混物血管支架的制备(4) Preparation of blend vascular stent

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT血管支架的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB-HH/PEG-CO-PBT,将膜裁剪成宽为38mm、长为100mm的尺寸,用直径为12mm的圆纸筒将双层膜卷起。The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT vascular stent in Example 1, except that the PHB-HV/PEG-CO-PBT is replaced by PHB-HH/PEG-CO-PBT, and the film is cut into For a size of 38 mm in width and 100 mm in length, the double-layer film is rolled up with a circular paper tube with a diameter of 12 mm.

实施例4:Example 4:

采用50%的聚羟基丁酸酯(PHB)/聚羟基丁酸-戊酸酯(PHB-HV)的共混物与50%的聚乙二醇/聚对本二甲酸丁二醇酯(PEG-CO-PBT)共聚物制备直径为3mm、长度为10mm的血管支架。A blend of 50% polyhydroxybutyrate (PHB)/polyhydroxybutyrate-valerate (PHB-HV) and 50% polyethylene glycol/polybutylene terephthalate (PEG- CO-PBT) copolymer to prepare a vascular stent with a diameter of 3 mm and a length of 10 mm.

(1)共混物实心膜的制备:(1) Preparation of blend solid film:

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT实心膜的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB/PHB-HV/PEG-CO-PBT,其中PEG-CO-PBT占总质量的50%,溶液浓度为0.05g/ml,将蒸发皿的直径调整为6cm;The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT solid film in Example 1, except that PHB-HV/PEG-CO-PBT is replaced by PHB/PHB-HV/PEG-CO-PBT, wherein PEG - CO-PBT accounts for 50% of the total mass, the solution concentration is 0.05g/ml, and the diameter of the evaporating dish is adjusted to 6cm;

(2)共混物多孔膜制备(2) Preparation of blend porous membrane

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT多孔膜的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB/PHB-HV/PEG-CO-PBT,其中PEG-CO-PBT占总质量的50%,加入NaCl为共混物总质量的15倍,将蒸发皿的直径调整为6cm;The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT porous membrane in Example 1, except that PHB-HV/PEG-CO-PBT is replaced by PHB/PHB-HV/PEG-CO-PBT, wherein PEG -CO-PBT accounts for 50% of the total mass, adding NaCl is 15 times the total mass of the blend, and adjusting the diameter of the evaporating dish to 6cm;

(3)共混物加强筋制备(3) Preparation of blend reinforcement

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT加强筋的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB/PHB-HV/PEG-CO-PBT;The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT reinforcing rib in Example 1, except that PHB-HV/PEG-CO-PBT is replaced by PHB/PHB-HV/PEG-CO-PBT;

(4)血管支架的制备(4) Preparation of stent

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT血管支架的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB/PHB-HV/PEG-CO-PBT,将膜裁剪成宽10mm、长10mm的条状,用直径3mm的圆纸筒将双层膜卷起。The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT vascular stent in Example 1, except that the PHB-HV/PEG-CO-PBT is replaced by PHB/PHB-HV/PEG-CO-PBT, and the membrane Cut into strips with a width of 10mm and a length of 10mm, and roll up the double-layer film with a circular paper tube with a diameter of 3mm.

实施例5:Example 5:

采用40%聚羟基丁酸酯(PHB)/聚羟基丁酸-己酸酯(PHB-HH)共混物与60%聚乙二醇/聚对本二甲酸丁二醇酯(PEG-CO-PBT)共聚物(PEG-CO-PBT)制备直径为8mm、长度为50mm的血管支架Using 40% polyhydroxybutyrate (PHB)/polyhydroxybutyrate-hexanoate (PHB-HH) blend with 60% polyethylene glycol/polybutylene terephthalate (PEG-CO-PBT) ) copolymer (PEG-CO-PBT) to prepare a vascular stent with a diameter of 8mm and a length of 50mm

(1)共混物实心膜制备(1) Blend solid film preparation

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT实心膜的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB/PHB-HH/PEG-CO-PBT,其中PEG-CO-PBT总质量的60%,溶液浓度0.1g/ml,将蒸发皿的直径调整为10cm;The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT solid film in Example 1, except that PHB-HV/PEG-CO-PBT is replaced by PHB/PHB-HH/PEG-CO-PBT, wherein PEG - 60% of the total mass of CO-PBT, the solution concentration is 0.1g/ml, and the diameter of the evaporating dish is adjusted to 10cm;

(2)共混物多孔膜制备(2) Preparation of blend porous membrane

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT多孔膜的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB/PHB-HH/PEG-CO-PBT,其中PEG-CO-PBT占总质量的60%,加入NaCl为共混物总质量的18倍,将蒸发皿的直径调整为10cm;The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT porous membrane in Example 1, except that PHB-HV/PEG-CO-PBT is replaced by PHB/PHB-HH/PEG-CO-PBT, wherein PEG -CO-PBT accounts for 60% of the total mass, adding NaCl is 18 times the total mass of the blend, and adjusting the diameter of the evaporating dish to 10cm;

(3)共混物加强筋的制备(3) Preparation of blend reinforcement

制备方法和实施例中制备PHB-HV/PEG-CO-PBT加强筋的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB/PHB-HH/PEG-CO-PBT;The preparation method is the same as the method for preparing PHB-HV/PEG-CO-PBT reinforcing ribs in the examples, except that PHB-HV/PEG-CO-PBT is replaced by PHB/PHB-HH/PEG-CO-PBT;

(4)共混物血管支架制备(4) Preparation of blend stent

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT血管支架的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB/PHB-HH/PEG-CO-PBT,将膜裁剪成宽25mm、长50mm的条状,用直径为8mm的圆纸筒将双层膜卷起。The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT vascular stent in Example 1, except that the PHB-HV/PEG-CO-PBT is replaced by PHB/PHB-HH/PEG-CO-PBT, and the membrane Cut into strips with a width of 25mm and a length of 50mm, and roll up the double-layer film with a circular paper tube with a diameter of 8mm.

实施例6:Embodiment 6:

采用30%聚羟基丁酸-戊酸酯(PHB-HV)/聚羟基丁酸-己酸酯(PHB-HH)共混物与70%聚乙二醇/聚对本二甲酸丁二醇酯(PEG-CO-PBT)共聚物制备直径为10mm、长度为50mm的血管支架Using 30% polyhydroxybutyrate-valerate (PHB-HV)/polyhydroxybutyrate-hexanoate (PHB-HH) blend with 70% polyethylene glycol/polybutylene terephthalate ( PEG-CO-PBT) copolymer preparation diameter is 10mm, the vascular stent that length is 50mm

(1)共混物实心膜制备(1) Blend solid film preparation

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT实心膜的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB-HV/PHB-HH/PEG-CO-PBT,其中PEG-CO-PBT占总质量的70%,溶液浓度0.08g/ml,将蒸发皿的直径调整为12cm;The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT solid film in Example 1, except that PHB-HV/PEG-CO-PBT is replaced by PHB-HV/PHB-HH/PEG-CO-PBT, Among them, PEG-CO-PBT accounts for 70% of the total mass, the solution concentration is 0.08g/ml, and the diameter of the evaporating dish is adjusted to 12cm;

(2)共混物多孔膜制备(2) Preparation of blend porous membrane

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT多孔膜的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB-HV/PHB-HH/PEG-CO-PBT,其中PEG-CO-PBT占总质量的70%,加入NaCl为共混物总质量的10倍,将蒸发皿的直径调整为12cm;The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT porous membrane in Example 1, except that PHB-HV/PEG-CO-PBT is replaced by PHB-HV/PHB-HH/PEG-CO-PBT, Wherein PEG-CO-PBT accounts for 70% of the total mass, adding NaCl is 10 times of the total mass of the blend, and the diameter of the evaporating dish is adjusted to 12cm;

(3)共混物加强筋制备(3) Preparation of blend reinforcement

制备方法和实施例一中制备PHB-HV/PEG-CO-PBT加强筋的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB-HV/PHB-HH/PEG-CO-PBT;The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT reinforcing rib in Example 1, except that PHB-HV/PEG-CO-PBT is replaced by PHB-HV/PHB-HH/PEG-CO-PBT;

(4)血管支架(4) Vascular stent

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT血管支架的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB-HV/PHB-HH/PEG-CO-PBT,将膜裁剪成宽32mm、长50mm的条状,用直径为10mm的圆纸筒将双层膜卷起。The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT vascular stent in Example 1, except that the PHB-HV/PEG-CO-PBT is replaced by PHB-HV/PHB-HH/PEG-CO-PBT, Cut the film into strips with a width of 32 mm and a length of 50 mm, and roll up the double-layer film with a circular paper tube with a diameter of 10 mm.

实施例7Example 7

采用70%聚羟基丁酸酯(PHB)/聚羟基丁酸-戊酸酯(PHB-HV)/聚羟基丁酸-己酸酯(PHB-HH)共混物与30%聚乙二醇/聚对本二甲酸丁二醇酯(PEG-CO-PBT)共聚物制备直径为10mm、长度为80mm血管支架。Using 70% polyhydroxybutyrate (PHB)/polyhydroxybutyrate-valerate (PHB-HV)/polyhydroxybutyrate-hexanoate (PHB-HH) blend with 30% polyethylene glycol/ Polybutylene terephthalate (PEG-CO-PBT) copolymer was used to prepare vascular stents with a diameter of 10 mm and a length of 80 mm.

(1)共混物实心膜制备(1) Blend solid film preparation

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT实心膜的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB/PHB-HV/PHB-HH/PEG-CO-PBT,其中PEG-CO-PBT占总重量的30%,溶液浓度0.03g/ml,将蒸发皿的直径调整为12cm;The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT solid film in Example 1, except that PHB-HV/PEG-CO-PBT is replaced by PHB/PHB-HV/PHB-HH/PEG-CO- PBT, wherein PEG-CO-PBT accounts for 30% of the total weight, the solution concentration is 0.03g/ml, and the diameter of the evaporating dish is adjusted to 12cm;

(2)共混物多孔膜制备(2) Preparation of blend porous membrane

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT多孔膜的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB/PHB-HV/PHB-HH/PEG-CO-PBT,其中PEG-CO-PBT占总重量的30%,加入NaCl为共混物总质量的15倍,将蒸发皿的直径调整为12cm;The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT porous membrane in Example 1, except that PHB-HV/PEG-CO-PBT is replaced by PHB/PHB-HV/PHB-HH/PEG-CO- PBT, wherein PEG-CO-PBT accounts for 30% of the total weight, adding NaCl is 15 times of the total mass of the blend, and the diameter of the evaporating dish is adjusted to 12cm;

(3)共混物加强筋制备(3) Preparation of blend reinforcement

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT加强筋的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB/PHB-HV/PHB-HH/PEG-CO-PBT;The preparation method is the same as the method for preparing PHB-HV/PEG-CO-PBT reinforcing ribs in Example 1, except that PHB-HV/PEG-CO-PBT is replaced by PHB/PHB-HV/PHB-HH/PEG-CO- PBT;

(4)血管支架的制备(4) Preparation of stent

制备方法和实施例1中制备PHB-HV/PEG-CO-PBT血管支架的方法相同,只是将PHB-HV/PEG-CO-PBT换成PHB/PHB-HV/PHB-HH/PEG-CO-PBT,将膜裁剪成宽32mm、长80mm的条状,用直径为10mm的圆纸筒将双层膜卷起。The preparation method is the same as the method for preparing the PHB-HV/PEG-CO-PBT vascular stent in Example 1, except that the PHB-HV/PEG-CO-PBT is replaced by PHB/PHB-HV/PHB-HH/PEG-CO- For PBT, cut the film into strips with a width of 32 mm and a length of 80 mm, and roll up the double-layer film with a circular paper tube with a diameter of 10 mm.

Claims (4)

1. polyhydroxyalkanoate intravascular stent, it is characterized in that: this intravascular stent is made of porous inner membrance, solid adventitia and reinforcement, and reinforcement is wrapped in solid adventitia top layer with band shape; Described porous inner membrance, solid adventitia and reinforcement are that the blend by polyhydroxyalkanoate and Polyethylene Glycol/polybutylene terephthalate (PBT) copolymer is prepared from.
2. according to the described intravascular stent of claim 1, it is characterized in that: described polyhydroxyalkanoate is a kind of in poly butyric ester, poly butyric-valerate, the poly butyric-alkyl caproate or their blend.
3. according to the described intravascular stent of claim 1, it is characterized in that: 1~2 millimeter of the thickness of described porous inner membrance and solid adventitia; The thickness of described reinforcement is 2~4 millimeters, and its width is 3~5 millimeters.
4. one kind prepares the method for intravascular stent as claimed in claim 1 or 2, it is characterized in that this method comprises the steps:
(1) preparation of blend solid membrane:
1. 30~80% polyhydroxyalkanoate, Polyethylene Glycol/polybutylene terephthalate (PBT) of 20~70% is copolymer blended, be solvent with the chloroform, heating in water bath is mixed with the uniform solution that concentration is 0.03g/ml~0.1g/ml;
2. adopt the method for casting film-forming, will pour in the secondary culture dish after the solution cooling of step in 1., culture dish fastening up and down, chloroform is volatilized naturally, vacuum drying makes solid membrane;
(2) preparation of blend perforated membrane
1. Sal is crossed standard screen, choose the NaCl particle of diameter in the 50-300 mu m range;
2. Polyethylene Glycol/the polybutylene terephthalate (PBT) of 30~80% polyhydroxyalkanoate and 20~70% is copolymer blended, be solvent with the chloroform, heating in water bath is mixed with the uniform solution that concentration is 0.03g/ml~0.1g/ml;
3. add the NaCl particle in 2. solution, wherein NaCl accounts for polyhydroxyalkanoate and Polyethylene Glycol/polybutylene terephthalate (PBT) gross mass 10~20 times, heats then, stirs, and makes suspension;
4. adopt the method for casting film-forming, pour in the secondary culture dish after the prepared suspension liquid cooling in will be 3.,, chloroform is volatilized naturally culture dish fastening up and down;
5. sample in taking out 4. immerses it in deionized water, regularly changes water, takes out perforated membrane after a period of time, and earlier in indoor seasoning, vacuum drying is stand-by then;
(3) preparation of blend reinforcement
1. the solid membrane that makes in (1) being cut into width range is 3~5mm strip;
2. the strip solid membrane is being lower than even heating under the temperature of fusing point, is stackedly putting and be bonded together 2~3, making reinforcement with chloroform;
(4) preparation of intravascular stent
1. according to actual needs the solid membrane, perforated membrane and the reinforcement that make in (1), (2), (3) are cut out and become suitable dimensions; Then solid membrane and perforated membrane are kept flat, behind the even heating, gently press the bonding double-layered compound film of making;
2. the composite membrane that obtains is rolled, seam crossing is done the binding agent heat bonding with chloroform, the compound tube of adventitia in obtaining; Again reinforcement is wrapped on the tube, can obtains complete intravascular stent.
CNB031192777A 2003-03-07 2003-03-07 Polyhydroxyalkanoates (PHA) blood vessel support and making method thereof Expired - Fee Related CN1258382C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB031192777A CN1258382C (en) 2003-03-07 2003-03-07 Polyhydroxyalkanoates (PHA) blood vessel support and making method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB031192777A CN1258382C (en) 2003-03-07 2003-03-07 Polyhydroxyalkanoates (PHA) blood vessel support and making method thereof

Publications (2)

Publication Number Publication Date
CN1433818A true CN1433818A (en) 2003-08-06
CN1258382C CN1258382C (en) 2006-06-07

Family

ID=27634507

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB031192777A Expired - Fee Related CN1258382C (en) 2003-03-07 2003-03-07 Polyhydroxyalkanoates (PHA) blood vessel support and making method thereof

Country Status (1)

Country Link
CN (1) CN1258382C (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100357343C (en) * 2004-05-19 2007-12-26 清华大学 Method for preparing porous polymer film
CN103607975A (en) * 2011-06-03 2014-02-26 美国医疗设备有限公司 Esophageal stent
US9474638B2 (en) 2013-03-05 2016-10-25 Merit Medical Systems, Inc. Reinforced valve
US9687367B2 (en) 2012-06-05 2017-06-27 Merit Medical Systems, Inc. Esophageal stent
US9713522B2 (en) 2011-10-31 2017-07-25 Merit Medical Systems, Inc. Esophageal stent with valve
US10588762B2 (en) 2013-03-15 2020-03-17 Merit Medical Systems, Inc. Esophageal stent

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100357343C (en) * 2004-05-19 2007-12-26 清华大学 Method for preparing porous polymer film
CN103607975A (en) * 2011-06-03 2014-02-26 美国医疗设备有限公司 Esophageal stent
CN103607975B (en) * 2011-06-03 2016-08-17 麦瑞通医疗设备有限公司 Esophageal Stent
US10285798B2 (en) 2011-06-03 2019-05-14 Merit Medical Systems, Inc. Esophageal stent
US9713522B2 (en) 2011-10-31 2017-07-25 Merit Medical Systems, Inc. Esophageal stent with valve
US9687367B2 (en) 2012-06-05 2017-06-27 Merit Medical Systems, Inc. Esophageal stent
US9474638B2 (en) 2013-03-05 2016-10-25 Merit Medical Systems, Inc. Reinforced valve
US10588762B2 (en) 2013-03-15 2020-03-17 Merit Medical Systems, Inc. Esophageal stent

Also Published As

Publication number Publication date
CN1258382C (en) 2006-06-07

Similar Documents

Publication Publication Date Title
JP4555800B2 (en) Method for producing porous polymer support for tissue engineering using gel radiation molding method
CN1166413C (en) Surgical prosthesis
CN1837274A (en) Biodegradable and absorbable polymer nanofiber membrane material and its preparation method and use
CN102217981B (en) Multi-layer hernia repairing patch and preparation method thereof
CN101574541A (en) Method for preparing high-strength rib grads multi-aperture bracket
CN103736153A (en) Single-layer and double-layer polycaprolactone-based guided tissue regeneration membranes and preparation method thereof
CN1440818A (en) Collagen material and its producing method
CN106178121B (en) An X-ray imaging blood vessel substitute and preparation method thereof
CN103071189B (en) Preparation method of collagen film for guided tissue regeneration
CN104001208B (en) Preparation method for biomacromolecule/chitin nanocrystalline composite scaffold material
CN105457096A (en) Preparation methods of degradable tussah fibroin tissue engineering scaffold material with good biocompatibility
CN102166372B (en) Manufacturing method of composite nanofiber scaffold for promoting repair of bone defect
CN1433818A (en) Polyhydroxyalkanoates (PHA) blood vessel support and making method thereof
CN102764171B (en) A kind of electrostatic spinning composite vascular stent and preparation method thereof
CN1586655A (en) Method for preparing multilayer medicine composite degradable biliary tract rack visible under X-ray
CN109130403A (en) A kind of compound sticking patch and preparation method thereof that prevents adhesion of alginate bonding
CN1223383C (en) Angiosupport made of polyamide and polyhydroxy fatty acid ester comixture and its preparation method
CN1367023A (en) Preparation method of biodegradable medicine composite macromolecular scaffold material
WO2022236125A1 (en) Photocurable reinforcement of 3d printed hydrogel objects
CN1883718A (en) High molecular film coated scaffold
CN1215887C (en) Vascular stent made of polyhydroxyalkanoate and its copolymer and its preparation method
CN1613434A (en) Growth inducing stand for animal tissue
CN102836015B (en) A kind of new electrostatic spinning compound rest and preparation method thereof
CN1568907A (en) Artificial endovascular stent and preparation method thereof
CN1724081A (en) Calcium sulfate composite porous scaffold material with polymer and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060607